5N Plus Inc.

VNP

CA33833X1015

Specialty Chemicals

Delayed Toronto S.E. Other stock markets 01:09:47 2024-04-24 pm EDT			5-day change	1st Jan Change
4.68 ^CAD	-1.68%		-0.43%	+23.81%

Apr. 18	Toronto Stocks Advance; Lithium Americas Shares Down on Discounted Pricing for $275 Million Public Offering	DJ
Apr. 18	5n Plus Up More Than 2% After US Department of Defense Awards It a US$14.4 Million Contract	MT

5N Plus Inc. Appoints Gervais Jacques as Chief Executive Officer

March 21, 2022 at 07:33 am EDT

5N Plus Inc. announced that its Board of Directors has appointed Mr. Gervais Jacques as Chief Executive Officer (CEO), effective March 18, 2022. Mr. Jacques has been Interim President and CEO since December 1, 2021. He remains a member of the Board of Directors.

Latest news about 5N Plus Inc.

Toronto Stocks Advance; Lithium Americas Shares Down on Discounted Pricing for $275 Million Public Offering	Apr. 18	DJ
5n Plus Up More Than 2% After US Department of Defense Awards It a US$14.4 Million Contract	Apr. 18	MT
5N Plus Brief: Says Awarded US$14.4 Million by U.S. Department of Defense	Apr. 18	MT
5N Plus Inc. Wins Usd 14.4 Million by U.S. Department of Defense	Apr. 18	CI
National Bank Raises 5N Plus Target to $6, Reiterates Outperform	Mar. 21	MT
5N+ Says Patents "Uniquely Positioned" to Expedite First-to-Market Commercialization of Vertical GaN-on-Si Power Devices	Mar. 21	MT
5N Plus Inc. Launches the Commercialization Rights for Its Portfolio of Gallium Nitride on Silicon (Gan-On-Si) Patents	Mar. 21	CI
National Bank Reviews 5N Plus' Q4 Results	Feb. 29	MT
Transcript : 5N Plus Inc., Q4 2023 Earnings Call, Feb 28, 2024	Feb. 28
North American Morning Briefing : Stock Futures Fall Ahead of Key Inflation Data	Feb. 28	DJ
5N Plus Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 27	CI
5N Plus Inc. Reports Impairment Results for the Fourth Quarter of 2023	Feb. 27	CI
5N Plus Brief: Record reported Adjusted EBITDA of US$38.3 million in FY 2023; Adjusted gross margin of 29.0% for FY 2023; Net debt to EBITDA ratio of 1.69x as at December 31, 2023	Feb. 27	MT
5N Plus Brief: Net earnings of US$2.3 million in Q4 2023 and $15.4 million in FY 2023	Feb. 27	MT
North American Morning Briefing : Stock Futures Pause as Investors Eye Inflation Data	Feb. 27	DJ
North American Morning Briefing : Earnings Back in Focus Ahead of Fed Minutes	Feb. 20	DJ
National Bank Adjusts Price Target for Coverage Universe Across Sustainability, Cleantech Sector	Jan. 09	MT
National Bank of Canada Says 5N Plus Reaffirmed Visibility On Growing Demand For Semiconductor Products	Dec. 06	MT
Transcript : 5N Plus Inc., Q3 2023 Earnings Call, Nov 08, 2023	Nov. 08
National Bank Of Canada Says 5N Plus' Q3 Revenue Above Expectations	Nov. 08	MT
North American Morning Briefing : Stock Futures -2-	Nov. 08	DJ
5N Plus Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 07	CI
North American Morning Briefing : Higher Bond -2-	Nov. 07	DJ
National Bank Cuts Q3 Revenue Forecast for 5N Plus, Lowers 2023 Estimates; Provides Forecast for 2024, 2025	23-10-25	MT
5N Plus Inc.(TSX:VNP) added to S&P Global BMI Index	23-09-18	CI

Chart 5N Plus Inc.

Duration

Period

More charts

Company Profile

5N Plus Inc. is a global producer of specialty semiconductors and performance materials. The Company deploys a range of technologies to develop and manufacture its products. It operates through two segments: Specialty Semiconductors and Performance Materials. Operating in North America and Europe, the Specialty Semiconductors segment manufactures and sells products used in several applications, such as renewable energy, space satellites and imaging. Its end markets include photovoltaics (terrestrial and spatial solar energy), medical imaging, infrared imaging, optoelectronics, and advanced electronics. The Performance Materials segment operates in North America, Europe and Asia and manufactures and sells products that are used in several applications in pharmaceutical and healthcare, industrial, and extractive and catalytic. Main products are sold as active pharmaceutical ingredients, animal feed additives, specialized chemicals, commercial grade metals, alloys, and engineered powders.

Sector

Specialty Chemicals

Calendar

2024-04-30 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for 5N Plus Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

3.482 USD

Average target price

4.356 USD

Spread / Average Target

+25.12%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Specialty Chemicals

	1st Jan change	Capi.
5N PLUS INC.	+23.81%	309M
ECOLAB INC.	+10.92%	62.8B
SIKA AG	-5.19%	45.4B
GIVAUDAN SA	+15.01%	40.32B
FUJIFILM HOLDINGS CORPORATION	+20.63%	25.83B
EMS-CHEMIE HOLDING AG	+5.07%	18.21B
CELANESE CORPORATION	-0.56%	17.41B
SYMRISE AG	+4.48%	15.64B
POSCO FUTURE M CO., LTD.	-17.27%	15.51B
ALBEMARLE CORPORATION	-21.74%	13.42B

Other Specialty Chemicals

5N Plus Inc.

Equities

VNP

CA33833X1015

Specialty Chemicals

5N Plus Inc. Appoints Gervais Jacques as Chief Executive Officer

EPS Revisions